MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 561 to 580 of 166,322 approvalsPage 29 of 8317

Indobufen Tablets

Approval Number: 国药准字H20258072
Registration: Apr 30, 2025
呋欧医药科技（湖州）有限公司

Roxadustat Capsules

Approval Number: 国药准字H20254047
Registration: Apr 30, 2025
四川国为制药有限公司

Nimodipine Oral Solution

Approval Number: 国药准字H20254009
Registration: Apr 30, 2025
湖南先施制药有限公司

Calcium Acetate Tablets

Approval Number: 国药准字H20254053
Registration: Apr 30, 2025
吉林省辉南长龙生化药业股份有限公司

Roxadustat Capsules

Approval Number: 国药准字H20254048
Registration: Apr 30, 2025
四川国为制药有限公司

Meloxicam Injection (Ⅱ)

Approval Number: 国药准字H20250012
Registration: Apr 30, 2025
南京清普生物科技有限公司

Nimodipine Oral Solution

Approval Number: 国药准字H20254010
Registration: Apr 30, 2025
湖南先施制药有限公司

Lornoxicam for Injection

Approval Number: 国药准字H20254046
Registration: Apr 30, 2025
成都米子生物医药科技有限公司

Recombinant Human Follitropin for Injection

Approval Number: 国药准字S20250018
Registration: Apr 30, 2025
成都景泽生物制药有限公司

Calcium Gluconate and Sodium Chloride Injection

Approval Number: 国药准字H20254015
Registration: Apr 30, 2025
广东科泓药业有限公司

Composite Potassium Hydrogen Phosphate Injection

Approval Number: 国药准字H20254014
Registration: Apr 30, 2025
南京恩泰医药科技有限公司

Levodopa and Benserazide Hydrochloride Tablets

Approval Number: 国药准字H20254060
Registration: Apr 30, 2025
安徽贝克生物制药有限公司

Norepinephrine Bitartrate Injection

Approval Number: 国药准字H20254039
Registration: Apr 30, 2025
江苏联环药业股份有限公司

Minoxidil Liniment

Approval Number: 国药准字H20254032
Registration: Apr 30, 2025
江苏知原药业股份有限公司

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20254042
Registration: Apr 30, 2025
石药集团欧意药业有限公司

Levodopa and Benserazide Hydrochloride Tablets

Approval Number: 国药准字H20254055
Registration: Apr 30, 2025
广东稳健药业有限公司

Erythromycin Enteric-coated Tablets

Approval Number: 国药准字H13020896
Registration: Apr 30, 2025
河北金砖药业有限公司

Cobamamide Capsules

Approval Number: 国药准字H20254021
Registration: Apr 30, 2025
河北东圣科宇医药科技有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.